128 related articles for article (PubMed ID: 18078860)
1. High-sensitivity C-reactive protein level is a significant risk factor for silent cerebral infarction in patients on hemodialysis.
Anan F; Shimomura T; Kaku T; Kaneda K; Imagawa M; Tsukagawa H; Masaki T; Nawata T; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2008 Jan; 57(1):66-70. PubMed ID: 18078860
[TBL] [Abstract][Full Text] [Related]
2. Predictors for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis.
Anan F; Shimomura T; Imagawa M; Masaki T; Nawata T; Takahashi N; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2007 May; 56(5):593-8. PubMed ID: 17445532
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinemia is a significant risk factor for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis.
Anan F; Takahashi N; Shimomura T; Imagawa M; Yufu K; Nawata T; Nakagawa M; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2006 May; 55(5):656-61. PubMed ID: 16631443
[TBL] [Abstract][Full Text] [Related]
4. Association between plasma high-sensitivity C-reactive protein and insulin resistance and white matter lesions in Japanese type 2 diabetic patients.
Anan F; Masaki T; Kikuchi H; Iwao T; Shimomura T; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
Diabetes Res Clin Pract; 2010 Feb; 87(2):233-9. PubMed ID: 19931932
[TBL] [Abstract][Full Text] [Related]
5. Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus.
Kawamura T; Umemura T; Kanai A; Nagashima M; Nakamura N; Uno T; Nakayama M; Sano T; Hamada Y; Nakamura J; Hotta N
Metabolism; 2006 Apr; 55(4):461-6. PubMed ID: 16546476
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity C-reactive protein is associated with hippocampus volume in nondementia patients with type 2 diabetes mellitus.
Anan F; Masaki T; Shimomura T; Fujiki M; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2011 Apr; 60(4):460-6. PubMed ID: 20537668
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein (a) as a risk factor for silent cerebral infarction in hemodialysis patients.
Fukunaga N; Anan F; Kaneda K; Nawata T; Saikawa T; Yoshimatsu H
Metabolism; 2008 Oct; 57(10):1323-7. PubMed ID: 18803933
[TBL] [Abstract][Full Text] [Related]
8. Silent cerebral infarction in patients with type 2 diabetic nephropathy. Effects of antiplatelet drug dilazep dihydrochloride.
Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Ebihara I; Koide H
Diabetes Metab Res Rev; 2005; 21(1):39-43. PubMed ID: 15386824
[TBL] [Abstract][Full Text] [Related]
9. Association between C-reactive protein and biomarkers of bone and mineral metabolism in chronic hemodialysis patients: a cross-sectional study.
Lee CT; Tsai YC; Ng HY; Su Y; Lee WC; Lee LC; Chiou TT; Liao SC; Hsu KT
J Ren Nutr; 2009 May; 19(3):220-7. PubMed ID: 19243976
[TBL] [Abstract][Full Text] [Related]
10. Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure.
Windram JD; Loh PH; Rigby AS; Hanning I; Clark AL; Cleland JG
Am Heart J; 2007 Jun; 153(6):1048-55. PubMed ID: 17540208
[TBL] [Abstract][Full Text] [Related]
11. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
[TBL] [Abstract][Full Text] [Related]
12. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
Habib SS
J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
[TBL] [Abstract][Full Text] [Related]
13. Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis.
Lin-Tan DT; Lin JL; Wang LH; Wang LM; Huang LM; Liu L; Huang JY; Huang YL
J Am Soc Nephrol; 2007 Aug; 18(8):2385-91. PubMed ID: 17599971
[TBL] [Abstract][Full Text] [Related]
14. Body mass index and cardiovascular risk factors and biomarkers in hemodialysis patients.
Bossola M; Giungi S; Panocchia N; Vulpio C; Luciani G; Tazza L
J Nephrol; 2008; 21(2):197-204. PubMed ID: 18446714
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation.
Tam LS; Tomlinson B; Chu TT; Li M; Leung YY; Kwok LW; Li TK; Yu T; Zhu YE; Wong KC; Kun EW; Li EK
Rheumatology (Oxford); 2008 May; 47(5):718-23. PubMed ID: 18400833
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk factors in non-diabetic hemodialysis patients: a comparative study.
Tzanatos HA; Tseke PP; Pipili C; Retsa K; Skoutelis G; Grapsa E
Ren Fail; 2009; 31(2):91-7. PubMed ID: 19212904
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
[TBL] [Abstract][Full Text] [Related]
18. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D deficiency and associated factors in hemodialysis patients.
Jean G; Charra B; Chazot C
J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
